142 related articles for article (PubMed ID: 27449273)
21. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
22. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
Schottenfeld RS; Chawarski MC; Cubells JF; George TP; Lappalainen J; Kosten TR
Drug Alcohol Depend; 2014 Mar; 136():36-42. PubMed ID: 24462581
[TBL] [Abstract][Full Text] [Related]
23. Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.
Clarke TK; Ambrose-Lanci L; Ferraro TN; Berrettini WH; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Lohoff FW
Genes Brain Behav; 2012 Jun; 11(4):415-23. PubMed ID: 22443215
[TBL] [Abstract][Full Text] [Related]
24. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.
Ahmadi J; Kampman KM; Oslin DM; Pettinati HM; Dackis C; Sparkman T
Am J Addict; 2009; 18(1):81-6. PubMed ID: 19219669
[TBL] [Abstract][Full Text] [Related]
25. Outcome predictors in cocaine dependence treatment trials.
Ahmadi J; Kampman K; Dackis C
Am J Addict; 2006; 15(6):434-9. PubMed ID: 17182445
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.
Clarke TK; Crist RC; Ang A; Ambrose-Lanci LM; Lohoff FW; Saxon AJ; Ling W; Hillhouse MP; Bruce RD; Woody G; Berrettini WH
Pharmacogenomics J; 2014 Jun; 14(3):303-8. PubMed ID: 24126707
[TBL] [Abstract][Full Text] [Related]
27. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.
Zhang H; Kranzler HR; Yang BZ; Luo X; Gelernter J
Mol Psychiatry; 2008 May; 13(5):531-43. PubMed ID: 17622222
[TBL] [Abstract][Full Text] [Related]
28. The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.
Clarke TK; Weiss AR; Ferarro TN; Kampman KM; Dackis CA; Pettinati HM; O'brien CP; Oslin DW; Lohoff FW; Berrettini WH
Ann Hum Genet; 2014 Jan; 78(1):33-9. PubMed ID: 24359476
[TBL] [Abstract][Full Text] [Related]
29. Topiramate for the treatment of cocaine addiction: a randomized clinical trial.
Johnson BA; Ait-Daoud N; Wang XQ; Penberthy JK; Javors MA; Seneviratne C; Liu L
JAMA Psychiatry; 2013 Dec; 70(12):1338-46. PubMed ID: 24132249
[TBL] [Abstract][Full Text] [Related]
30. Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial.
Reis AD; Castro LA; Faria R; Laranjeira R
Braz J Psychiatry; 2008 Jun; 30(2):132-5. PubMed ID: 18470406
[TBL] [Abstract][Full Text] [Related]
31. An analysis of genetic association in opioid dependence susceptibility.
Nagaya D; Zahari Z; Saleem M; Yahaya BH; Tan SC; Yusoff NM
J Clin Pharm Ther; 2018 Feb; 43(1):80-86. PubMed ID: 28656735
[TBL] [Abstract][Full Text] [Related]
32. Genetic Architecture and Molecular Neuropathology of Human Cocaine Addiction.
Huggett SB; Stallings MC
J Neurosci; 2020 Jul; 40(27):5300-5313. PubMed ID: 32457073
[TBL] [Abstract][Full Text] [Related]
33. Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial.
Mariani JJ; Pavlicova M; Bisaga A; Nunes EV; Brooks DJ; Levin FR
Biol Psychiatry; 2012 Dec; 72(11):950-6. PubMed ID: 22795453
[TBL] [Abstract][Full Text] [Related]
34. Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder.
Crist RC; Phillips KA; Furnari MA; Moran LM; Doyle GA; McNicholas LF; Cornish JW; Kampman KM; Preston KL; Berrettini WH
Pharmacogenomics J; 2019 Jun; 19(3):260-268. PubMed ID: 30368523
[TBL] [Abstract][Full Text] [Related]
35. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.
Umbricht A; DeFulio A; Winstanley EL; Tompkins DA; Peirce J; Mintzer MZ; Strain EC; Bigelow GE
Drug Alcohol Depend; 2014 Jul; 140():92-100. PubMed ID: 24814607
[TBL] [Abstract][Full Text] [Related]
36. Variant detection at the delta opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence.
Gelernter J; Kranzler HR
Hum Genet; 2000 Jul; 107(1):86-8. PubMed ID: 10982041
[TBL] [Abstract][Full Text] [Related]
37. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.
Elkashef A; Kahn R; Yu E; Iturriaga E; Li SH; Anderson A; Chiang N; Ait-Daoud N; Weiss D; McSherry F; Serpi T; Rawson R; Hrymoc M; Weis D; McCann M; Pham T; Stock C; Dickinson R; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Li MD; Johnson BA
Addiction; 2012 Jul; 107(7):1297-306. PubMed ID: 22221594
[TBL] [Abstract][Full Text] [Related]
38. Case-control association study of WLS variants in opioid and cocaine addicted populations.
Crist RC; Ambrose-Lanci LM; Zeng A; Yuan C; Kampman KM; Pettinati HM; Oslin DW; O'Brien CP; Ferraro TN; Doyle GA; Lohoff FW; Berrettini WH
Psychiatry Res; 2013 Jun; 208(1):62-6. PubMed ID: 23566366
[TBL] [Abstract][Full Text] [Related]
39. Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands.
Nuijten M; Blanken P; van den Brink W; Hendriks V
Drug Alcohol Depend; 2014 May; 138():177-84. PubMed ID: 24629631
[TBL] [Abstract][Full Text] [Related]
40. Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study.
Lai H; Stitzer M; Treisman G; Moore R; Brinker J; Gerstenblith G; Kickler TS; Li J; Chen S; Fishman E; Lai S
J Addict Med; 2015; 9(4):331-9. PubMed ID: 26164164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
